Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 2/20 | 0.49 |
| ▸ | PDE4A | P27815 | 1/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.43 |
| ▸ | GSR | P00390 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL103446 | 0.82 | NAAA (0.34) | ADRA2APDE4AADRA1AALDH1A1SMN1; SMN2 | |
| SCHEMBL3342253 | 0.74 | ALDH1A1 (0.46) | ADRA2APDE4AADRA1AALDH1A1SMN1; SMN2 | |
| SCHEMBL29393349 | 0.73 | ALDH1A1 (0.53) | ADRA2APDE4AADRA1AALDH1A1SMN1; SMN2 | |
| SCHEMBL9295642 | 0.72 | — | — | |
| SCHEMBL178740 | 0.72 | ADRA2A (0.53) | ADRA2APDE4AADRA1AALDH1A1SMN1; SMN2 | |
| SCHEMBL9013125 | 0.71 | ADRA2A (0.37) | ADRA2APDE4AADRA1AALDH1A1SMN1; SMN2 | |
| SCHEMBL10893189 | 0.70 | ALDH1A1 (0.42) | ADRA2APDE4AADRA1AALDH1A1SMN1; SMN2 | |
| SCHEMBL178738 | 0.69 | ALDH1A1 (0.44) | ADRA2APDE4AADRA1AALDH1A1SMN1; SMN2 | |
| SCHEMBL10879162 | 0.68 | TDP1 (0.46) | ADRA2APDE4AADRA1AALDH1A1SMN1; SMN2 | |
| SCHEMBL103096 | 0.67 | BCHE (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8728442-B2 | Method of controlling the growth of microorganisms by a composition containing isolated or in vitro synthesized nitrosoamides | BAYER CROPSCIENCE LP (US) | 2014-05-20 | — | — | US | disclosed |
| US-20120058058-A1 | COMPOUNDS DERIVED FROM MUSCODOR FUNGI | AGRAQUEST, INC. (US) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058058-A1 | COMPOUNDS DERIVED FROM MUSCODOR FUNGI | SPOUT1, ERG28, DDT | ADRA2A 4219/4885PDE4A 435/4885ADRA1A 4252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.